A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced it ...

Myriad Genetics’ first quarter results were met with a significant negative market reaction, reflecting investor concerns over a combination of volume softness in key product lines and a reset ...

Read about Myriad Genetics Inc (MYGN:XNAS) stock and today's latest news and financial updates.

Myriad Genetics’ first quarter results were met with a significant negative market reaction, reflecting investor concerns over a combination of volume softness in key product lines and a reset ...

What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market ...

Myriad Genetics Inc. Annual stock financials by MarketWatch. View the latest MYGN financial statements, income statements and financial ratios.

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else ...

CSHL’s Lippman and McCandlish labs have discovered how interactions between cryptic genetic mutations can increase or decrease the number of reproductive branches on tomato plants. The scientists’ ...

British scientists have created eight children in a lab over the past two years whose health continues to be monitored in hopes of determining if research methods that incorporate a third parent in ...

When it comes to groundbreaking biotech advancements, Eric Faw Intellia is a name you might wanna keep an eye on. This article gonna dive deep into Eric Faw ...

Overview of Companion Diagnostics MarketThe Companion Diagnostics Market is evolving rapidly, driven by the growing demand ...